1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. ソース別スニペット
3.2. タイプ別スニペット
3.3. 用途別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 乳児栄養の需要増加
4.1.1.2. オメガ3 PUFAの健康効果に対する消費者の意識の高まり
4.1.2. 阻害要因
4.1.2.1. 持続可能性と環境への懸念
4.2. 機会
4.3. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. ロシア・ウクライナ戦争の影響分析
5.6. DMI意見
6. 情報源別
6.1. はじめに
6.1.1. ソース別市場規模分析および前年比成長率分析（%）.
6.1.2. 市場魅力度指数, 供給源別
6.2. 海洋資源
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. 魚油
6.2.4. クリルオイル
6.2.5. 藻類オイル
6.2.6. その他のオイル
6.3. 植物由来
6.3.1. 亜麻仁油
6.3.2. チアシードオイル
6.3.3. ヘンプオイル
6.3.4. その他のオイル
7. 種類別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, タイプ別
7.1.2. 市場魅力度指数（タイプ別
7.2. α-リノール酸（ALA）*市場
7.2.1. 序論
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. ドコサヘキサエン酸（DHA）
7.4. エイコサペンタエン酸（EPA）
8. 用途別
8.1. はじめに
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、用途別
8.2. 食品と飲料
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 栄養補助食品
8.4. 医薬品
8.5. その他の用途
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析(%)、供給源別
9.2.4. 市場規模分析および前年比成長率分析（%）, タイプ別
9.2.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.2.6. 市場規模分析および前年比成長率分析（%）, 国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析およびYoY成長率分析(%)、供給源別
9.3.4. 市場規模分析および前年比成長率分析（%）, タイプ別
9.3.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.3.6. 市場規模分析および前年比成長率分析(%)、国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. イタリア
9.3.6.5. スペイン
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析(%)、供給源別
9.4.4. 市場規模分析とYoY成長率分析（%）, タイプ別
9.4.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.4.6. 市場規模分析および前年比成長率分析(%)、国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析およびYoY成長率分析(%), 供給源別
9.5.4. 市場規模分析および前年比成長率分析（%）, タイプ別
9.5.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.5.6. 市場規模分析および前年比成長率分析（%）, 国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. オーストラリア
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析およびYoY成長率分析(%)、供給源別
9.6.4. 市場規模分析および前年比成長率分析（%）, タイプ別
9.6.5. 市場規模分析および前年比成長率分析（%）, 用途別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Cargill, Incorporated.*
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. DSM
11.3. Corbion
11.4. Croda International Plc
11.5. ADM
11.6. Arista Industries, Inc.
11.7. Omega Protein Corporation
11.8. Goerlich Pharma GmbH
11.9. Evonik
11.10. Nu-Mega Ingredients (*リストは除く)
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ
Global omega-3 PUFA Market reached US$ 2.4 billion in 2023 and is expected to reach US$ 4.4 billion by 2031, growing with a CAGR of 7.9% during the forecast period 2024-2031.
Due to growing consumer awareness and demand for nutrients that improve health, the Omega-3 Polyunsaturated Fatty Acids (PUFAs) market is expanding rapidly. Key Omega-3s, including Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), are valued for their anti-inflammatory, cardiovascular and cognitive benefits. Increased disposable incomes worldwide, particularly in developing economies like Asia where health-conscious consumer behavior is on the rise, are supporting the trend.
Recent trends indicate a growing diversification in Omega-3 sources and products. Traditionally sourced from fatty fish, Omega-3s are now available in a variety of forms, including plant-based alternatives like flaxseed and chia seed oils, catering to vegan and vegetarian consumers. Furthermore, advancements in algae-based supplements have broadened market offerings, providing additional options for obtaining these essential nutrients. The diversification aligns with the broader trend of incorporating health benefits into everyday foods and supplements.
In September 2023, Corbion, a global leader in algae-based feed ingredients, introduced AlgaPrime DHA P3, a groundbreaking omega-3 ingredient designed to enhance pet food nutrition. The new product significantly boosts DHA (docosahexaenoic acid) levels, offering a high-performance solution that reduces reliance on marine sources and lowers the carbon footprint of pet food products.
Market Dynamics
Increasing Demand for Infant Nutrition
The study in Current Developments in Nutrition looks at what happens to a baby's body composition when docosahexaenoic acid (DHA) is given to the mother during pregnancy. Specifically, the study looks at fat mass (FM) and gestational weight gain (GWG). The Growth and Adiposity in Newborns Study (GAINS), which included 250 people from the ADORE trial, found that prenatal DHA increases baby fat mass by a lot without changing the GWG of the mother. The results were consistent across sexes and persisted through a 24-month follow-up, reinforcing the need for further research on long-term effects.
The increasing demand for infant nutrition, particularly in the omega-3 polyunsaturated fatty acids (PUFA) sector, reflects a growing awareness of the importance of prenatal nutrition. As evidence mounts regarding the benefits of omega-3 PUFAs, such as DHA, on infant fat distribution and overall body composition, there is a notable shift towards enhancing prenatal dietary interventions. It has resulted in an increased market demand for DHA-enriched supplements, driven by both consumer and healthcare provider interest in optimizing infant health from an early stage.
The growing body of evidence showing how DHA reduces the risk of childhood obesity and improves infant health outcomes is causing the market for omega-3 PUFA supplements to grow. The trend aligns with a broader movement towards preventative health measures and personalized nutrition strategies. As ongoing studies continue to validate the benefits of omega-3 PUFAs, the demand for such supplements is expected to grow, prompting innovation and increased investment in the sector.
Growing Consumer Awareness Of The Health Benefits Of Omega-3 PUFAs
Consumer awareness of the health benefits associated with omega-3 polyunsaturated fatty acids (PUFAs) has been increasing, driving growth in the omega-3 PUFA market. Omega-3 PUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well-regarded for their roles in reducing inflammation, enhancing cardiovascular health and supporting cognitive function. Increased awareness is influencing consumer preferences and behaviors, particularly among athletes and health-conscious individuals seeking to improve performance and recovery through dietary supplements.
The market for omega-3 PUFAs is expanding as more individuals seek to incorporate these beneficial fats into their diets. Increased awareness of omega-3s' positive effects on health, their efficacy in reducing inflammation, and their potential to improve athletic performance and recovery are the trends driving factors. As a result, there is a growing market for supplements and functional foods enriched with omega-3 PUFAs, catering to the rising consumer demand for health-promoting products.
Sustainability and Environmental Concerns
Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) are three important omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) that are very important for human health and nutrition. Traditionally, these nutrients are sourced from marine fish, krill and algae. However, the availability of these marine resources is either stagnant or on the decline, presenting significant sustainability challenges.
As per MDPI, the overfishing of wild marine species to meet the growing demand for ω3 LC-PUFA has led to substantial environmental impacts. Furthermore, climate change threatens to diminish global DHA levels by 10 to 58% by 2100, primarily due to the reduced availability of microalgae, the fundamental source of ω3 LC-PUFA in the marine food chain. The situation exacerbates the strain on marine ecosystems and contributes to the decline of fish stocks.
Aquaculture offers an alternative to wild fishing for ω3 LC-PUFA, yet it depends on the sustainable provision of these nutrients. The reliance on marine-based ω3 LC-PUFA sources for farmed fish limits the potential of aquaculture to address the depletion of wild fish populations effectively. Thus, the availability and environmental impact of its nutrient sources limit the sustainability of aquaculture.
Segment Analysis
The global omega-3 PUFA market is segmented based on source, type, application and region.
The Surging Demand for Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)
News Medical Life Sciences reports that a new study on omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), shows that they may help treat acne. This is in line with a larger trend of rising consumer demand for these compounds. Research highlights the anti-inflammatory properties of DHA and EPA, showing that these omega-3 fatty acids may help reduce acne severity. It aligns with the growing consumer awareness of the health benefits of omega-3 fatty acids, which is driving increased demand for these ingredients in dietary supplements and functional foods.
In addition, the study's findings on the efficacy of DHA and EPA in treating acne contribute to the expanding applications of these fatty acids in dermatology and skincare. The evidence supporting the use of DHA and EPA for skin health is fueling market growth as consumers seek products that offer these benefits. The trend is part of a broader movement towards preventive health and wellness, with individuals increasingly turning to dietary supplements to support overall well-being, including skin health.
Geographical Penetration
Rising Demand for Omega-3 PUFA in North America
North America is expected to be the dominant region in the global omega-3 PUFA market holding an approximate market share of 35% during the forecast period. The partnership between DSM-Firmenich and SCN BestCo represents a pivotal moment in the evolution of omega-3 polyunsaturated fatty acids (PUFAs) within the North American market. Fish oil soft gels have historically dominated the market, but despite their effectiveness, they came with drawbacks like a fishy aftertaste, large capsule size, and environmental issues related to overfishing.
As consumer awareness of omega-3 benefits for heart health, cognitive function and overall wellness grew, so did the demand for more palatable and sustainable alternatives. In response to increasing consumer demand for plant-based and environmentally friendly options, the market began to shift towards algal-based omega-3 supplements. The products offered a sustainable, vegetarian-friendly alternative to traditional fish oil, addressing concerns about overfishing and the ecological impact of omega-3 production.
In March 2024, the collaboration between dsm-Firmenich and SCN BestCo is a direct response to these evolving consumer preferences. By leveraging dsm-Firmenich’s life’s OMEGA O33-P100, an algal-based omega-3 powder, the partnership has successfully developed high-load omega-3 gummies. The gummies provide over 400 mg of EPA and DHA per two-piece serving, significantly surpassing the typical dosage levels found in traditional omega-3 gummies.
Competitive Landscape
The major global players in the market include Cargill, Incorporated, DSM, Corbion, Croda International Plc, ADM, Arista Industries, Inc., Omega Protein Corporation, Goerlich Pharma GmbH, Evonik and Nu-Mega Ingredients.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine war has significantly impacted the omega-3 polyunsaturated fatty acids (PUFA) market. The conflict has disrupted supply chains and increased production costs due to rising prices of raw materials and logistics challenges. The war has also led to economic instability in the region, affecting consumer purchasing power and demand for omega-3 PUFA products.
Furthermore, the sanctions imposed on Russia have complicated trade relationships, limiting access to key markets and affecting the overall availability of omega-3 PUFA products in the region. As a result, the market is experiencing uncertainty and volatility, with companies needing to adapt to the rapidly changing geopolitical landscape.
By Source
Marine Sources
Fish Oil
Krill Oil
Algae Oil
Other Oils
Plant Sources
Flaxseed Oil
Chia Seed Oil
Hemp Oil
Other Oils
By Type
Alpha linoleic acid (ALA)
Docosahexaenoic acid (DHA)
Eicosapentaenoic acid (EPA)
By Application
Food and Beverages
Dietary Supplements
Pharmaceuticals
Other Applications
By Region
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa
Key Developments
In April 2024, FrieslandCampina introduced two innovative DHA ingredients, Biotis DHA FlexP 15 and Biotis DHA FlexP 20, tailored for the adult nutrition market. The high-load, algae-based, microencapsulated DHA powders are designed for vegan and vegetarian formulations, offering exceptional sensory qualities.
In March 2024, Epax introduced EPAX Omega 3-9-11, the first concentrated oil combining long-chain monounsaturated fatty acids (LC-MUFAs) and long-chain polyunsaturated fatty acids (LC-PUFAs), derived from North Atlantic pelagic fish. The innovative product, rich in Omega-3 (EPA and DHA), Omega-9 and Omega-11 is developed using Epax EQP+ Tech, a specialized distillation process enhancing fatty acid content.
In January 2024, Ritual introduced its Omega-3 DHA + EPA supplement, offering a 500 mg dose of omega-3 fatty acids in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in La Forêt-Fouesnant, France, the supplement is produced using patented technology to minimize oxidation and reduce burp-back, with natural citrus oil added for improved taste.
Why Purchase the Report?
To visualize the global omega-3 PUFA market segmentation based on source, type, application and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the omega-3 PUFA market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The global omega-3 PUFA market report would provide approximately 62 tables, 53 figures and 219 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Source
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Infant Nutrition
4.1.1.2. Growing consumer awareness of the health benefits of omega-3 PUFAs
4.1.2. Restraints
4.1.2.1. Sustainability and Environmental Concerns
4.2. Opportunity
4.3. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. By Source
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
6.1.2. Market Attractiveness Index, By Source
6.2. Marine Sources*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Fish Oil
6.2.4. Krill Oil
6.2.5. Algae Oil
6.2.6. Other Oils
6.3. Plant Sources
6.3.1. Flaxseed Oil
6.3.2. Chia Seed Oil
6.3.3. Hemp Oil
6.3.4. Other Oils
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Alpha linoleic acid (ALA)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Docosahexaenoic acid (DHA)
7.4. Eicosapentaenoic acid (EPA)
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Food and Beverages*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Dietary Supplements
8.4. Pharmaceuticals
8.5. Other Applications
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. US
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Cargill, Incorporated.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. DSM
11.3. Corbion
11.4. Croda International Plc
11.5. ADM
11.6. Arista Industries, Inc.
11.7. Omega Protein Corporation
11.8. Goerlich Pharma GmbH
11.9. Evonik
11.10. Nu-Mega Ingredients (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
*** オメガ-3 PUFAの世界市場に関するよくある質問(FAQ) ***
・オメガ-3 PUFAの世界市場規模は？
→DataM Intelligence社は2023年のオメガ-3 PUFAの世界市場規模を24億米ドルと推定しています。
・オメガ-3 PUFAの世界市場予測は？
→DataM Intelligence社は2031年のオメガ-3 PUFAの世界市場規模を44億米ドルと予測しています。
・オメガ-3 PUFA市場の成長率は？
→DataM Intelligence社はオメガ-3 PUFAの世界市場が2024年～2031年に年平均7.9%成長すると展望しています。
・世界のオメガ-3 PUFA市場における主要プレイヤーは？
→「Cargill, Incorporated、DSM、Corbion、Croda International Plc、ADM、Arista Industries, Inc、Omega Protein Corporation、Goerlich Pharma GmbH、Evonik、Nu-Mega Ingredientsなど ...」をオメガ-3 PUFA市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
